BioArctic AB (OSTO:BIOA B)
kr 238.4 5 (2.14%) Market Cap: 21.06 Bil Enterprise Value: 20.57 Bil PE Ratio: 0 PB Ratio: 21.21 GF Score: 55/100

Full Year 2019 BioArctic AB Earnings Call Transcript

Feb 06, 2020 / 08:30AM GMT
Release Date Price: kr82.65 (-3.22%)
Operator

Hello, and welcome to the BioArctic Q4 Report 2019. (Operator Instructions)

Just to remind you, the conference call is being recorded. Today, I'm pleased to present CEO, Gunilla Osswald; and CFO, Jan Mattsson. Please go ahead with your meeting.

Gunilla Osswald;publ;CEO
BioArctic AB

()-

Thank you, and welcome to the full year report of 2019 for BioArctic. I'm Gunilla Osswald, and I'm the CEO of BioArctic, and I will share the presentation today here with our CFO, Jan Mattsson.

I'm happy to be here today and present another successful year for BioArctic with a strengthened cash position and an enhanced project portfolio, which has expanded and progressed well during the year.

Next slide, please. BioArctic is listed on nasdaq.com midcap, and this is our disclaimer.

Next slide, please. For those of you who are new to BioArctic, I'll give a short introduction to the company. BioArctic is a unique Swedish biopharma company with the aim to improve lives for patients with CNS disorders. I think that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot